N.M. Admin. Code § 16.2.18.22

Current through Register Vol. 35, No. 23, December 10, 2024

Section 16.2.18.22 - INTRAVENOUS THERAPY EDUCATIONAL COURSE CURRICULUM

The intravenous therapy educational course curriculum shall provide the doctor of oriental medicine, who successfully completes the course, with the knowledge and skills defined in Section 10 of 16.2.18 NMAC and the following specific knowledge and skills.

A. Pharmaceutical law: knowledge of compatibility and sterile compounding procedures of authorized substances in the intravenous therapy formulary in compliance with the compounding requirements of the USP-797.

B. Diagnostic phlebotomy knowledge of:

(1) and skill in drawing blood for diagnostic purposes using appropriate aseptic procedure;

(2) needles, lancets, winged sets, syringes, vacutainer tubes, and other equipment used to draw blood for diagnostic purposes; and

(3) the various blood tests most relevant to the protocols being taught.

C. Intravenous therapy knowledge of:

(1) and skill in the use of the equipment used for intravenous infusions;

(2) equipment used for an intravenous push;

(3) equipment used for injecting a bolus into an infusion;

(4) local anatomy of common infusion sites and skill in selecting an appropriate infusion site;

(5) authorized substances that are appropriate or not appropriate for intravenous infusion or injection from the intravenous therapy formulary;

(6) concept and importance of osmolarity, pH and skill in determining pH and calculating a given solution's osmolarity using an osmolarity chart simple algebraic equation or computer software;

(7) prerequisite lab tests that should be evaluated prior to initiating intravenous therapy of any kind;

(8) and skill in preparing and administering an intravenous push, intravenous infusion and injecting a bolus into an IV infusion; and

(9) possible complications that could occur during an intravenous infusion or push and how to identify, treat and manage these complications.

D. Oxidative medicine, photo-oxidation and the use of oxygen therapeutically knowledge of:

(1) biochemistry of oxidative medicine including the biological electron transfer sequence (BETS) oxidation and reduction (redox) reactions;

(2) and skill in the relevant clinical application and use of the authorized substances in the intravenous therapy formulary;

(3) history, physics, equipment and therapeutic use of ultraviolet blood irradiation (photoluminescence);

(4) history, physics, physiology and therapeutic use, contraindications and safety considerations of hyperbaric oxygen chamber therapy; and

(5) blood borne pathogen training.

E. Detoxification and chelation therapy knowledge of:

(1) diagnostic tools available for determining and tracking the therapeutic elimination of body burden of toxic elements including hair analysis, blood analysis and urinalysis with provocation agents;

(2) how to determine that the kidneys, colon and liver are functioning appropriately prior to commencement of detoxification or chelation diagnostic and therapeutic procedures;

(3) critical importance of, and methods for, optimizing kidney and bowel function, and phase 1/phase 2 liver detox pathways, prior to and during detoxification or chelation therapy, how to recognize when these systems are overburdened and what to do if they are overburdened;

(4) biochemistry, clinical use, and safety concerns relevant to all modes of administration of the authorized substances used in detoxification or chelation therapy; and

(5) how to explain to the patient the purpose of the therapy, the expected outcome, alternatives and possible complications of the therapy that could occur.

N.M. Admin. Code § 16.2.18.22

Adopted by New Mexico Register, Volume XXVI, Issue 11, June 16, 2015, eff. 6/16/2015